이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!
Bliss GVS Pharma 과거 수익 실적
과거 기준 확인 4/6
Bliss GVS Pharma의 수입은 연평균 -9.6%의 비율로 감소해 온 반면, Pharmaceuticals 산업은 수입이 연평균 15.6%의 비율로 증가했습니다. 매출은 연평균 0.9%의 비율로 증가해 왔습니다. Bliss GVS Pharma의 자기자본이익률은 8.9%이고 순이익률은 10.3%입니다.
주요 정보
-9.6%
수익 성장률
-9.9%
EPS 성장률
Pharmaceuticals 산업 성장 | 17.5% |
매출 성장률 | 0.9% |
자기자본 수익률 | 8.9% |
순이익 | 10.3% |
최근 수익 업데이트 | 30 Jun 2024 |
최근 과거 실적 업데이트
Recent updates
These 4 Measures Indicate That Bliss GVS Pharma (NSE:BLISSGVS) Is Using Debt Safely
Aug 25Bliss GVS Pharma Limited's (NSE:BLISSGVS) Prospects Need A Boost To Lift Shares
Aug 07Increases to Bliss GVS Pharma Limited's (NSE:BLISSGVS) CEO Compensation Might Cool off for now
Jul 19Bliss GVS Pharma's (NSE:BLISSGVS) Dividend Will Be ₹0.50
Jul 18Bliss GVS Pharma (NSE:BLISSGVS) Is Due To Pay A Dividend Of ₹0.50
Jul 04We Think Bliss GVS Pharma's (NSE:BLISSGVS) Solid Earnings Are Understated
May 10Bliss GVS Pharma Limited's (NSE:BLISSGVS) Price Is Right But Growth Is Lacking
Apr 27Does Bliss GVS Pharma (NSE:BLISSGVS) Have A Healthy Balance Sheet?
Feb 20There Is A Reason Bliss GVS Pharma Limited's (NSE:BLISSGVS) Price Is Undemanding
Jan 26Does Bliss GVS Pharma (NSE:BLISSGVS) Have A Healthy Balance Sheet?
Jul 14Bliss GVS Pharma (NSE:BLISSGVS) Has Affirmed Its Dividend Of ₹0.50
Sep 11Bliss GVS Pharma (NSE:BLISSGVS) Is Due To Pay A Dividend Of ₹0.50
Aug 28These 4 Measures Indicate That Bliss GVS Pharma (NSE:BLISSGVS) Is Using Debt Reasonably Well
May 21Estimating The Intrinsic Value Of Bliss GVS Pharma Limited (NSE:BLISSGVS)
Apr 08A Look At Bliss GVS Pharma's (NSE:BLISSGVS) Share Price Returns
Mar 18Here's How We Evaluate Bliss GVS Pharma Limited's (NSE:BLISSGVS) Dividend
Feb 25Bliss GVS Pharma (NSE:BLISSGVS) Has A Pretty Healthy Balance Sheet
Feb 08What Type Of Shareholders Make Up Bliss GVS Pharma Limited's (NSE:BLISSGVS) Share Registry?
Jan 21Do Its Financials Have Any Role To Play In Driving Bliss GVS Pharma Limited's (NSE:BLISSGVS) Stock Up Recently?
Jan 08How Is Bliss GVS Pharma's (NSE:BLISSGVS) CEO Paid Relative To Peers?
Dec 26Did Bliss GVS Pharma's (NSE:BLISSGVS) Share Price Deserve to Gain 14%?
Dec 13Should You Use Bliss GVS Pharma's (NSE:BLISSGVS) Statutory Earnings To Analyse It?
Nov 30Bliss GVS Pharma Limited (NSE:BLISSGVS) Insiders Increased Their Holdings
Nov 18Does Bliss GVS Pharma Limited (NSE:BLISSGVS) Have A Place In Your Dividend Portfolio?
Nov 06Is Bliss GVS Pharma (NSE:BLISSGVS) A Risky Investment?
Oct 25Is Bliss GVS Pharma Limited's (NSE:BLISSGVS) Recent Stock Performance Influenced By Its Fundamentals In Any Way?
Oct 07How Much Is Bliss GVS Pharma Limited (NSE:BLISSGVS) CEO Getting Paid?
Sep 19What Is The Ownership Structure Like For Bliss GVS Pharma Limited (NSE:BLISSGVS)?
Sep 04수익 및 비용 분석
수익 및 비용 분석
Bliss GVS Pharma 수익 창출 및 지출 방식. 최근 보고된 수익 기준, LTM 기준.
수익 및 매출 내역
날짜 | 수익 | 수익 | G+A 비용 | R&D 비용 |
---|---|---|---|---|
30 Jun 24 | 7,944 | 815 | 1,424 | 0 |
31 Mar 24 | 7,702 | 755 | 1,394 | 0 |
31 Dec 23 | 7,569 | 879 | 1,234 | 0 |
30 Sep 23 | 7,619 | 883 | 1,213 | 0 |
30 Jun 23 | 7,224 | 598 | 1,190 | 0 |
31 Mar 23 | 7,516 | 709 | 1,160 | 0 |
31 Dec 22 | 7,339 | 871 | 1,284 | 0 |
30 Sep 22 | 7,444 | 91 | 1,256 | 0 |
30 Jun 22 | 7,680 | 165 | 1,235 | 0 |
31 Mar 22 | 7,475 | 150 | 1,045 | 0 |
31 Dec 21 | 7,124 | 17 | 896 | 0 |
30 Sep 21 | 6,602 | 773 | 876 | 0 |
30 Jun 21 | 6,158 | 766 | 698 | 0 |
31 Mar 21 | 5,772 | 685 | 827 | 0 |
31 Dec 20 | 5,650 | 710 | 763 | 0 |
30 Sep 20 | 5,487 | 692 | 730 | 0 |
30 Jun 20 | 6,073 | 797 | 582 | 0 |
31 Mar 20 | 6,893 | 973 | 684 | 0 |
31 Dec 19 | 8,136 | 1,066 | 835 | 0 |
30 Sep 19 | 8,861 | 1,087 | 805 | 0 |
30 Jun 19 | 9,044 | 1,192 | 525 | 0 |
31 Mar 19 | 8,986 | 1,237 | 748 | 0 |
31 Dec 18 | 3,788 | 623 | 234 | 0 |
30 Sep 18 | 3,543 | 543 | 300 | 0 |
30 Jun 18 | 3,521 | 469 | 369 | 0 |
31 Mar 18 | 3,720 | 297 | 432 | 0 |
31 Dec 17 | 9,063 | 1,098 | 1,669 | 0 |
30 Sep 17 | 9,423 | 1,053 | 1,659 | 0 |
30 Jun 17 | 8,843 | 860 | 1,627 | 0 |
31 Mar 17 | 4,033 | 509 | 654 | 0 |
31 Dec 16 | 6,711 | 664 | 944 | 0 |
30 Sep 16 | 5,755 | 742 | 853 | 0 |
30 Jun 16 | 5,911 | 836 | 370 | 0 |
31 Mar 16 | 5,469 | 825 | 782 | 0 |
31 Mar 15 | 4,071 | 599 | 764 | 0 |
31 Mar 14 | 3,446 | 410 | 828 | 0 |
양질의 수익: BLISSGVS 은 높은 수익을 보유하고 있습니다.
이익 마진 증가: BLISSGVS 의 현재 순이익 이익률 (9.8%) 작년보다 높습니다 (9.4%).
잉여현금흐름 대 수익 분석
과거 수익 성장 분석
수익추이: BLISSGVS 의 수입은 지난 5년 동안 매년 14.2% 씩 감소했습니다.
성장 가속화: 지난 1년간 BLISSGVS 의 수익 증가율( 36.2% )은 연간 평균( -9.6% 초과합니다. ).
수익 대 산업: 지난 1년간 BLISSGVS 수익 증가율( 36.2% )은 Pharmaceuticals 업계 19.3% 초과했습니다.
자기자본 수익률
높은 ROE: BLISSGVS 의 자본 수익률( 8.9% )은 낮음으로 간주됩니다.